299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02325362 (ClinicalTrials.gov)	March 17, 2015	10/12/2014	Effect of Miglustaton the Nasal Potential Difference in Patients With Cystic Fibrosis Homozygous for ...	Single Center, Double-blind, Randomized, Placebo-controlled, Two-period/Two-treatment Crossover, Pro ...	Cystic Fibrosis	Drug: Miglustat ; placebo;Drug: Placebo ; Miglustat	Assistance Publique - Hôpitaux de Paris	Actelion;CRCM (Centres de Ressources et de Compétences de la Mucoviscidose)	Completed	18 Years	N/A	All	16	Phase 2/Phase 3	France
2	NCT00945347 (ClinicalTrials.gov)	July 2009	23/7/2009	Does a Nasal Instillation of MiglustatNormalize the Nasal Potential Difference in Cystic Fibrosis Pa ...	Does a Nasal Instillation of MiglustatNormalize the Nasal Potential Difference in Cystic Fibrosis Pa ...	Cystic Fibrosis	Drug: Miglustat;Drug: Placebo	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	NULL	Completed	14 Years	N/A	Both	10	Phase 2	Belgium
3	EUCTR2008-002352-20-BE (EUCTR)	11/08/2008	17/07/2008	Single center, double-blind, randomized, placebo-controlled, two-period/two-treatment crossover stud ...	Single center, double-blind, randomized, placebo-controlled, two-period/two-treatment crossover stud ...	Cystic fibrosis homozygous for the F508del mutation MedDRA version: 9.1;Level: LLT;Classification co ...	Trade Name: Zavesca INN or Proposed INN: miglustat	Actelion Pharmaceuticals Ltd	NULL	Not Recruiting			Female: yes Male: yes			Belgium
4	NCT00742092 (ClinicalTrials.gov)	August 2008	26/8/2008	Miglustat in Cystic Fibrosis	Single Center, Double-blind, Randomized, Placebo-controlled, Two-period/Two-treatment Crossover Stud ...	Cystic Fibrosis	Drug: miglustat;Drug: placebo	Actelion	NULL	Completed	12 Years	N/A	Both	11	Phase 2	Belgium
5	NCT00537602 (ClinicalTrials.gov)	November 2007	28/9/2007	Miglustat / OGT 918 in the Treatment of Cystic Fibrosis	Single Center, Double-blind, Randomized, Placebo-controlled, 2-period/2-treatment Crossover Study In ...	Cystic Fibrosis	Drug: miglustat;Drug: placebo	Actelion	NULL	Terminated	12 Years	N/A	Both	6	Phase 2	Spain
6	EUCTR2006-002049-35-ES (EUCTR)	22/07/2007	28/05/2007	Estudio unicéntrico, a doble ciego, aleatorizado y controlado con placebo, cruzado de 2 brazos, para ...	Estudio unicéntrico, a doble ciego, aleatorizado y controlado con placebo, cruzado de 2 brazos, para ...	fibrosis quística MedDRA version: 8.1;Level: LLT;Classification code 10011762;Term: Cystic fibrosis	Trade Name: Zavesca Product Name: miglustat Product Code: OGT 918 INN or Proposed INN: Miglustat Other d ...	Actelion Pharmaceuticals Ltd	NULL	Not Recruiting			Female: yes Male: yes	25	Phase 2	Spain

First Previous1Next Last